Showing results (2061-2070 of 2,560) with videos related to

Sort By:
Pageof 256
Cancer Medicine|April 25, 2022
Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillanceLauren Brady, Lisa F Newcomb, Kehao Zhu, et al.
Prostate Cancer and Prostatic Diseases|May 4, 2016
Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomiesM S Tretiakova, W Wei, H D Boyer, et al.
Clinical Chemistry|November 21, 2007
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancerDale McLerran, William E Grizzle, Ziding Feng, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2016
Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISHTamara L Lotan, Wei Wei, Olga Ludkovski, et al.
Cancer Research|July 7, 2018
IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor MicroenvironmentTatiana A Karakasheva, Eric W Lin, Qiaosi Tang, et al.
The Prostate|June 22, 2016
Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy CohortJames D Brooks, Wei Wei, Jonathan R Pollack, et al.
Nature Neuroscience|June 14, 2016
Lrp4 in astrocytes modulates glutamatergic transmissionXiang-Dong Sun, Lei Li, Fang Liu, et al.
Journal of Medicinal Chemistry|March 7, 2003
Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolinesPhilip R Kym, Michael E Kort, Michael J Coghlan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancerAnita L Sabichi, Seth P Lerner, E Neely Atkinson, et al.
Biomarker Research|November 10, 2024
Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillanceJustin R Gregg, Lisa Newcomb, Ranran Wu, et al.
Pageof 256